| Product NDC: | 0115-5213 |
| Proprietary Name: | COLESTIPOL HYDROCHLORIDE |
| Non Proprietary Name: | COLESTIPOL HYDROCHLORIDE |
| Active Ingredient(s): | 5 g/1 & nbsp; COLESTIPOL HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0115-5213 |
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077277 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060502 |
| Package NDC: | 0115-5213-02 |
| Package Description: | 100 SUSPENSION in 1 BOTTLE (0115-5213-02) |
| NDC Code | 0115-5213-02 |
| Proprietary Name | COLESTIPOL HYDROCHLORIDE |
| Package Description | 100 SUSPENSION in 1 BOTTLE (0115-5213-02) |
| Product NDC | 0115-5213 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | COLESTIPOL HYDROCHLORIDE |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20060502 |
| Marketing Category Name | ANDA |
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| Substance Name | COLESTIPOL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |